The First Conference in Japan for Asian New Drug Development
The conference will highlight issues on Chinese regulation and infrastructure for clinical trials, Current status of regulation and clinical trials in Asian countries and Asian development strategy and clinical operations
An efficient global development strategy, based on US and European experiences, has been adopted by many Japanese companies. Today, Asian multinational studies have been planned and conducted in sites in Japan and mainland China. Therefore, this workshop will provide an opportunity to discuss the Asian development strategy.
We have invited experts from China to participate in this conference. With their support, we will discuss Asian development issues, especially involving China and Japan.
As for the discussion of Asian development strategy, Japanese regulatory representatives and speakers from China will be invited.
At the reception on the first day, an informative presentation, “What is the DIA World”, will be offered.
Target Audience:
This program will benefit:
· Clinical development professionals
· Personnel at clinical study sites
· Personnel at CROs and SMOs
Contact Information:
CONTACT AND TABLETOP EXHIBIT INFORMATION
Attendees are welcome to visit the limited tabletop exhibitsduring the meeting and receptions. For meeting and tabletop exhibit information, contact:
Yuka Nakamura at the Drug Information Association, LLC office in Tokyo by telephone +81-(0)3-5511-1131, fax +81-(0)3-5511-0100 or email [email protected]
http://www.diahome.org/DIAHome/Education/FindEducationalOffering.aspx?pr...
